PT  - JOURNAL ARTICLE
AU  - Puterman, Eli
AU  - Hives, Benjamin A.
AU  - Mazara, Nicole
AU  - Grishin, Nikol
AU  - Webster, Joshua
AU  - Hutton, Stacey
AU  - Koehle, Michael
AU  - Liu, Yan
AU  - Beauchamp, Mark R
TI  - The COvid-19 Pandemic and Exercise (COPE) Trial: A multi-group randomized controlled trial comparing effects of an app-based, at-home exercise program to waitlist control on depressive symptoms
AID  - 10.1101/2021.04.14.21255519
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.14.21255519
4099  - http://medrxiv.org/content/early/2021/04/20/2021.04.14.21255519.short
4100  - http://medrxiv.org/content/early/2021/04/20/2021.04.14.21255519.full
AB  - Background The number of adults across the globe with significant depressive symptoms has grown substantially during the COVID-19 pandemic. The extant literature supports exercise as a potent behavior that can significantly reduce depressive symptoms in clinical and non-clinical populations.Objective Using a suite of mobile applications, at-home exercise, including high intensity interval training (HIIT) and/or yoga, was completed to reduce depressive symptoms in the general population in the early months of the pandemic.Methods A 6-week, parallel, multi-arm, randomized controlled trial was completed with 4 groups: [1] HIIT, [2] Yoga, [3] HIIT+Yoga, and [4] waitlist control (WLC). Low active, English-speaking, non-retired Canadians aged 18-64 years were included. Depressive symptoms were measured at baseline and weekly following randomization.Results A total of 334 participants were randomized to one of four groups. No differences in depressive symptoms were evident at baseline. The results of latent growth modeling showed significant treatment effects for each active group compared to the WLC, with small effect sizes in the community-based sample of participants. Treatment groups were not significantly different from each other. Effect sizes were very large when restricting analyses only to participants with high depressive symptoms at baseline.Conclusions At-home exercise is a potent behavior to improve mental health in adults during the pandemic, especially in those with increased levels of depressive symptoms. Promotion of at-home exercise may be a global public health target with important personal, social, and economic implications as the world emerges scathed by the pandemic.Trial registration number clinicaltrials.gov #NCT04400279Summary Box This randomized controlled trial provides strong evidence suggesting that at-home app-based exercise in various forms (high intensity interval training or yoga or their combination) can significantly improve depression symptoms over a 6-week period in community adults during the pandemic. When the sample was restricted to only those with high baseline depression symptoms, the weekly effects were substantially large. At-home exercise during the COVID-19 pandemic proved to be an impactful and affordable health behavior in which community living adults, especially those with high depression symptoms, can engage to bolster their mental health. In light of the long-term mental health consequences of COVID-19 with which many adults are expected to struggle, even after a return to normal, promoting and supporting programming in communities at the individual level will emerge as a necessary health policy initiative.Competing Interest StatementThe authors have declared no competing interest.Clinical Trial#NCT04400279Clinical Protocols https://osf.io/jbm63/ Funding StatementFunding for this research was provided by the Canada Research Chairs Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of British Columbia Behavioral Review Ethics BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data reported here will be available at Open Science Framework (https://osf.io/jbm63/ https://osf.io/jbm63/